No hay productos en el carrito



Acute Rejection. Risk Factors, Management and Complications
Kobayashi, T. — Arai, R.
1ª Edición Septiembre 2012
Inglés
Tapa dura
197 pags
438 gr
16 x 23 x 2 cm
ISBN 9781619423466
Editorial NOVA SCIENCE PUBLISHERS INC. U.S.
LIBRO IMPRESO
-5%
165,35 €157,08 €IVA incluido
158,99 €151,04 €IVA no incluido
Recíbelo en un plazo de
2 - 3 semanas
Description:
This book presents current research in the study of the risk factors, management and complications of acute rejection in transplant patients. Topics include the mechanisms, management and consequences of acute cellular and antibody mediated rejection in solid organ and reconstructive transplantation; donor specific antibody mediated humoral rejection and biological implications of B cells and novel nucleic acid drugs for the prevention of acute cardiac rejection. (Imprint: Nova Biomedical)
Table of Contents:
Preface
HLA and Non-HLA Genes Polymorphisms: Susceptibility and Severity in Tunisian
Patients with Rheumatoid Arthritis;pp. 1-46
(Tarak Dhaouadi, Imen Sfar, Leila Abdelmoula, Henda Krichen, Dorra Khazen, Houda
Aouadi, Saloua Jendoubi-Ayed, Taieb Ben Abdallah, Khaled Ayed, Rafik Zouari,
Yousr Gorgi, Immunology Research Laboratory in Kidney Transplantation and Immunopathology
(LR03SP01), University Tunis El Manar, Charles Nicolle Hospital, Tunisia, and
others)
Mechanisms, Management and Consequences of Acute Cellular and Antibody Mediated
Rejection in Solid Organ and Reconstructive Transplantation;pp. 47-82
(A. Weißenbacher, T. Hautz, B. Kern, J. Pratschke, S. Schneeberger, Center
of Operative Medicine, Department of Visceral, Transplant and Thoracic Surgery,
Innsbruck Medical University, Innsbruck, Austria)
Donor Specific Antibody (DSA) Mediated Humoral Rejection and Biological Implications
of B Cells in Human Solid Organ Transplantation;pp. 83-109
(Manuel Muro, Alexandre Bosch, Ruth López-Hernández, Francisco
Boix, Manuela López, José A. Campillo, Alfredo Minguela, Rocío
Álvarez-López, Immunology Service, University Hospital Virgen
Arrixaca, Murcia, Spain)
Acute Cellular Rejection: Diagnosis and Immune Mechanisms;pp. 111-130
(Erika Lamkowski Naka, Alvaro Pacheco e Silva Filho, Niels Olsen Saraiva Camara,
Federal University of São Paulo (UNIFESP), Brazil)
Presentation, Diagnosis and Treatment of Acute Rejection;pp. 131-149
(Karen L. Hardinger, Daniel C. Brennan, Department of Pharmacy Practice and
Administration, School of Pharmacy, University of Missouri-Kansas City, Missouri,
USA, and others)
Novel Nucleic Acid Drugs for Prevention of Acute Cardiac Rejection;pp. 151-159
(Jun-ichi Suzuki, Mitsuaki Isobe, Ryuichi Morishita, Ryozo Nagai, Department
of Advanced Clinical Science and Therapeutics, University of Tokyo, Japan, and
others)
Study of Proliferation Response of the HLA-DQB1 0302 Molecule Associated to
Acute Rejection Development in Liver Transplant and Soluble HLA Class I Depletion;pp.
161-184
(Manuel Muro, Luis Marin, Rosa Moya, Alfredo Minguela and Rocío Álvarez-López,
Immunology Service, University Hospital Virgen Arrixaca, Murcia, Spain)*
Index
© 2025 Axón Librería S.L.
2.149.0